These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23827473)

  • 1. 2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis.
    Mendoza N; Sánchez-Borrego R; Villero J; Baró F; Calaf J; Cancelo MJ; Coronado P; Estévez A; Fernández-Moya JM; González S; Llaneza P; Neyro JL; del Pino J; Rodríguez E; Ruiz E; Cano A;
    Maturitas; 2013 Sep; 76(1):99-107. PubMed ID: 23827473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis prevention, diagnosis, and therapy.
    NIH Consens Statement; 2000 Mar 27-29; 17(1):1-45. PubMed ID: 11525451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
    Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
    Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD
    Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines.
    Li-Yu J; Perez EC; Cañete A; Bonifacio L; Llamado LQ; Martinez R; Lanzon A; Sison M; ;
    Int J Rheum Dis; 2011 Aug; 14(3):223-38. PubMed ID: 21816018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture prevention in elderly women: treatment of osteoporosis is one approach, together with physical exercise and fall prevention.
    Prescrire Int; 1998 Oct; 7(37):155-9. PubMed ID: 10915424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.
    Menopause; 2021 Sep; 28(9):973-997. PubMed ID: 34448749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish Menopause Society position statement: Use of denosumab in postmenopausal women.
    Cano A; Silvan JM; Estévez A; Baró F; Villero J; Quereda F; Ferrer J; Mendoza N; Sánchez-Borrego R;
    Maturitas; 2014 Sep; 79(1):117-21. PubMed ID: 25042873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2010 North American Menopause Society position statement: Updates on screening, prevention and management of postmenopausal osteoporosis.
    Schnatz PF
    Conn Med; 2011 Sep; 75(8):485-7. PubMed ID: 21980680
    [No Abstract]   [Full Text] [Related]  

  • 18. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Menopause and bone].
    Lobersztajn A; Trémollières F
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F28-32. PubMed ID: 23036315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of osteoporosis in postmenopausal women.
    French L; Smith M; Shimp L
    J Fam Pract; 2002 Oct; 51(10):875-82. PubMed ID: 12401161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.